Innovative diagnostics company, Glyconics, has won an £85,000 Phase 1 grant from the Global Challenges Research Fund (GCRF) to explore the feasibility of implementing a novel low-cost point-of-care diagnostic platform for diabetic screening in developing countries.
Glyconics is a company at the forefront of diagnostic innovation, using infrared spectroscopy to analyse samples for markers of disease across a wide range of conditions.
Trafalgar House Meridian Business Park Norwich
Post Code: NR7 0TA
Country: United Kingdom
Membership Type: Professional Individual and Corporate <5